Dolby Laboratories (NYSE:DLB) Stock Price Breaks Below 200-Day Moving Average After Analyst Downgrade

Dolby Laboratories logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Dolby shares fell below their 200-day moving average, trading as low as $58.25 versus the $59.40 average and last at $58.60. Rosenblatt cut its price target from $85 to $80 but maintained a Buy rating.
  • The latest quarter beat estimates: revenue rose 21.7% year over year to $373.5 million, and EPS of $1.25 topped the $1.20 consensus.
  • Forward guidance was weaker than expected: Q1 FY2027 revenue guidance of $285–$305 million and EPS guidance of $0.41–$0.56 were below analyst estimates, while full-year revenue guidance also fell short of expectations.
  • Interested in Dolby Laboratories? Here are five stocks we like better.

Shares of Dolby Laboratories (NYSE:DLB - Get Free Report) crossed below its two hundred day moving average during trading on Tuesday after Rosenblatt Securities lowered their price target on the stock from $85.00 to $80.00. The stock has a two hundred day moving average of $59.40 and traded as low as $58.25. Rosenblatt Securities currently has a buy rating on the stock. Dolby Laboratories shares last traded at $58.6010, with a volume of 4,334,134 shares trading hands.

Other equities analysts also recently issued reports about the company. Zacks Research raised Dolby Laboratories from a "strong sell" rating to a "hold" rating in a research report on Friday. Weiss Ratings raised shares of Dolby Laboratories from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday, September 9th. Finally, Wall Street Zen cut shares of Dolby Laboratories from a "buy" rating to a "hold" rating in a report on Saturday, August 1st. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $85.00.

Read Our Latest Analysis on DLB

Insiders Place Their Bets

In related news, CAO Ryan Nicholson sold 1,183 shares of Dolby Laboratories stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total value of $77,226.24. Following the completion of the transaction, the chief accounting officer directly owned 34,453 shares in the company, valued at approximately $2,249,091.84. This trade represents a 3.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP John D. Couling sold 7,667 shares of the business's stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $58.78, for a total value of $450,666.26. Following the transaction, the senior vice president directly owned 166,803 shares of the company's stock, valued at $9,804,680.34. The trade was a 4.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 16,517 shares of company stock worth $995,963 in the last ninety days. Corporate insiders own 37.93% of the company's stock.

Recent Dolby Laboratories Headlines

Here are a few of the latest headlines about DLB:

  • Positive Sentiment: Fiscal Q4 revenue rose 21.7% year over year to $373.5 million, slightly exceeding estimates, while EPS of $1.25 also topped consensus. Dolby Laboratories fiscal 2026 results
  • Neutral Sentiment: FY2027 EPS guidance of $4.27–$4.42 brackets the $4.34 consensus estimate. Rosenblatt lowered its price target from $85 to $80 but retained a Buy rating. Rosenblatt rating and target
  • Negative Sentiment: Near-term guidance was notably weak: Q1 FY2027 revenue of $285–$305 million is well below the $358.3 million consensus, and EPS guidance of $0.41–$0.56 trails the $1.06 estimate. FY2027 revenue guidance of $1.4 billion also falls short of the $1.5 billion expectation, raising concerns that the strong quarter may not carry forward. Dolby guidance report

Hedge Funds Weigh In On Dolby Laboratories

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Bank of New York Mellon Corp acquired a new stake in Dolby Laboratories in the second quarter valued at approximately $253,289,000. First Trust Advisors LP lifted its stake in Dolby Laboratories by 6.2% in the third quarter. First Trust Advisors LP now owns 2,872,446 shares of the electronics maker's stock worth $168,814,000 after acquiring an additional 166,942 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Dolby Laboratories by 6.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,321,407 shares of the electronics maker's stock worth $79,357,000 after acquiring an additional 83,835 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC acquired a new position in Dolby Laboratories during the 3rd quarter worth approximately $40,429,000. Finally, Advisors Asset Management Inc. acquired a new position in Dolby Laboratories during the 3rd quarter worth approximately $34,670,000. Hedge funds and other institutional investors own 58.56% of the company's stock.

Dolby Laboratories Stock Performance

The stock's 50-day simple moving average is $60.90 and its 200 day simple moving average is $59.40. The company has a market capitalization of $5.49 billion, a PE ratio of 24.94 and a beta of 0.79.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its quarterly earnings data on Tuesday, November 17th. The electronics maker reported $1.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.20 by $0.05. The business had revenue of $373.54 million for the quarter, compared to analyst estimates of $372.76 million. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The company's revenue was up 21.7% on a year-over-year basis. During the same period last year, the business earned $0.99 EPS. Dolby Laboratories has set its Q1 2027 guidance at 0.410-0.560 EPS and its FY 2027 guidance at 4.270-4.420 EPS. On average, analysts expect that Dolby Laboratories will post 3.23 earnings per share for the current year.

Dolby Laboratories announced that its Board of Directors has initiated a share buyback program on Thursday, July 30th that allows the company to repurchase $350 million in shares. This buyback authorization allows the electronics maker to repurchase up to 7% of its stock through open market purchases. Share buyback programs are usually a sign that the company's board of directors believes its stock is undervalued.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines